ANTI-CXCR2 ANTIBODIES AND USES THEREOF

Provided are anti-CXCR2 antibodies and antigen-binding fragments thereof. The antibodies or fragments thereof specifically bind to N-terminal, extracellular domain of the CXCR2 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO:...

Full description

Saved in:
Bibliographic Details
Main Authors Shi, Xiaojie, Yang, Guang
Format Patent
LanguageEnglish
Published 20.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided are anti-CXCR2 antibodies and antigen-binding fragments thereof. The antibodies or fragments thereof specifically bind to N-terminal, extracellular domain of the CXCR2 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 2, a VH CDR3 of SEQ ID NO: 3, or any one of SQ ID NO: 7-14, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and a VL CDR3 of SEQ ID NO: 6, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and inflammatory diseases are also provided.
AbstractList Provided are anti-CXCR2 antibodies and antigen-binding fragments thereof. The antibodies or fragments thereof specifically bind to N-terminal, extracellular domain of the CXCR2 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 2, a VH CDR3 of SEQ ID NO: 3, or any one of SQ ID NO: 7-14, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and a VL CDR3 of SEQ ID NO: 6, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and inflammatory diseases are also provided.
Author Yang, Guang
Shi, Xiaojie
Author_xml – fullname: Shi, Xiaojie
– fullname: Yang, Guang
BookMark eNrjYmDJy89L5WRQc_QL8dR1jnAOMlIAMZ38XTxdg4FMF4XQYCAjxMM1yNXfjYeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxIcGGxkYGRkbG1kYmzoaGhOnCgAhSiX4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2022332835A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2022332835A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:51:33 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2022332835A13
Notes Application Number: US202017640309
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221020&DB=EPODOC&CC=US&NR=2022332835A1
ParticipantIDs epo_espacenet_US2022332835A1
PublicationCentury 2000
PublicationDate 20221020
PublicationDateYYYYMMDD 2022-10-20
PublicationDate_xml – month: 10
  year: 2022
  text: 20221020
  day: 20
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies ShanghaiTech University
RelatedCompanies_xml – name: ShanghaiTech University
Score 3.4261026
Snippet Provided are anti-CXCR2 antibodies and antigen-binding fragments thereof. The antibodies or fragments thereof specifically bind to N-terminal, extracellular...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title ANTI-CXCR2 ANTIBODIES AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221020&DB=EPODOC&locale=&CC=US&NR=2022332835A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlILSt2JtujR9KLKmLVVYO7pW-jbatYWBzOEq_vteQqd72tslgcsH3MfvktwBPFJa2RUbiRqAJtHMglQaaxjV7KIwGKOlWclgziSiYWa-5aO8Bx_bvzAyT-iPTI6IErVAeW-lvl7_B7E8-bZy81QusevzJUgdT-3QsSEAjK56ruNPYy_mKudONlOjRI4RIpKLjRErHaAjbQl58N9d8S9lvWtUglM4nCK_VXsGvXo1gGO-rb02gKNJd-WNZCd9m3NQx1H6qvGcJ4YiSDcWzhySnpKhWlTS0E_8OLiAh8BPeajhhPO__c2z2e7qyCX0EfnXV6CYjV5Ylv3MCoRxrNZZvaDCwtakMK2SNtcw3MfpZv_wLZyIplDEhj6Efvv1Xd-hhW3Le3kwv3S4eRM
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjVWq5JouBER6LIciCkLhGoLTQuGWwMFEhNTG4vx7zu7odpTb5OdZPaRzOPb3ZkBeCCksAo64D0ADV0xMr1QaEWJYmWZRinJjUJc5kxCEiTGSzpIW_CxzYURdUJ_RHFE1Kgl6nst7PX6_xLLFX8rN4_5Ow59Pvux7coNOtY4gFFl17G9aeRGTGbMTuZyOBM8XefFxYaIlQ4wyDa5PnhvDs9LWe86Ff8EDqcob1WfQqtcdaHDtr3XunA0aZ68kWy0b3MG8jCMRwpL2UyTOOlEPJhD0pUSNItSHHgzL_LP4d73YhYoOOHib3-LZL67Ov0C2oj8y0uQjErNTNN6ohnCOFqqtFwS7mFLPTPMnFQ96O-TdLWffQedIJ6MF-NR-HoNx5zFjbKm9qFdf32XN-ht6_xWHNIvTbl8Bg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-CXCR2+ANTIBODIES+AND+USES+THEREOF&rft.inventor=Shi%2C+Xiaojie&rft.inventor=Yang%2C+Guang&rft.date=2022-10-20&rft.externalDBID=A1&rft.externalDocID=US2022332835A1